Travere Therapeutics, Inc. TVTX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s invested capital?
- Travere Therapeutics, Inc. (TVTX) reported invested capital of $35.95M in Q1 2026.
- How has Travere Therapeutics, Inc.'s invested capital changed year-over-year?
- Travere Therapeutics, Inc.'s invested capital decreased by 40.8% year-over-year, from $60.73M to $35.95M.
- What is the long-term trend for Travere Therapeutics, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Travere Therapeutics, Inc.'s invested capital has grown at a -24.8% compound annual growth rate (CAGR), from $160.94M to $38.8M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).